Clinical Trials Directory

Trials / Completed

CompletedNCT01043445

-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.

G Protein-coupled Receptor in the Intestine (GPR 119) Stimulated GLP-1 Secretion

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Glostrup University Hospital, Copenhagen · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the impact of different ligands of GPR 119 (a G protein-coupled receptor in the intestine) on the secretion of the incretin hormones, GLP-1 and GIP.

Detailed description

We have found a new ligand for the GPR 119 receptor. This study evaluate the impact of this ligand on the incretion hormone responses, beta cell function and gall bladder function in healthy young men.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGPR 119 agonist, 2-oleyl glycerolEmulgation, 50 ml. containing 2g 2OG
DIETARY_SUPPLEMENTOleic acidEmulgation, 50 ml. containing 1.54g of oleic acid
DIETARY_SUPPLEMENTVehicleFifty milliliters of glycerol (Sigma-Aldrich; batch 32296AK, purity 99%) plus 5 ml 96% ethanol

Timeline

Start date
2009-09-01
Primary completion
2010-03-01
Completion
2010-04-01
First posted
2010-01-06
Last updated
2014-10-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01043445. Inclusion in this directory is not an endorsement.